Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Planisware SA is a leading business-to-business provider of innovative Software-as-a-Service (SaaS) solutions for project portfolio management in the rapidly growing Project Economy. Founded in 1996, the company offers cloud-based platforms like Planisware Enterprise and Planisware Orchestra, which help organizations strategize, plan, and deliver complex projects, programs, and products with enhanced visibility, resource optimization, and AI-driven insights. These solutions address strategic planning, portfolio prioritization, budget management, risk assessment, capacity planning, scheduling, and collaboration across diverse sectors including IT and digital transformation, product development, professional services, engineering, construction, energy, aerospace, pharmaceuticals, and automotive. Serving around 600 customers worldwide, including global blue-chip firms and public sector entities, Planisware operates through 16 offices across more than 35 countries, with a workforce of approximately 750 employees as of late 2024. Its AI-powered features, such as predictive analytics, particle swarm optimization, and intelligent agents, enable data-driven decisions, scenario modeling, and efficient execution to master change at scale. Planisware SA plays a pivotal role in empowering organizations to align projects with strategic goals, maximize returns, and achieve higher success rates in dynamic environments.
Margins and capital returns are both well above average: 30.68% operating margin, ROIC at 22.49%. Consistent with durable pricing power, though that alone doesn't make it a buy.
Revenue grew 7.9%, steady but not accelerating.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
€198M
▲ +7.9% YoY
Net Income (TTM)
€50M
▲ +17.0% YoY
Op. Margin
30.68%
▲ +2.4pp YoY
ROIC
22.49%
▲ +0.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€63M
▲ +17.8% YoY
Op. Cash Flow (TTM)
€63M
▲ +17.8% YoY
Net Debt
-€181M
Net Cash Position
Cash & Equiv.
€199M
3Y CAGR: +14.5%
3Y CAGR: +28.9%
Continue Research